Test 12

The chart shows the growth of an initial investment of €10,000 in Test 12, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Jun 20, 2023, Test 12's average daily return is +0.10%, while the average monthly return is +2.07%. At this rate, your investment would double in approximately 2.8 years.

Historically, 71% of months were positive and 29% were negative. The best month was Jan 2026 with a return of +6.6%, while the worst month was Mar 2026 at -2.2%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 3 months.

On a daily basis, Test 12 closed higher 59% of trading days. The best single day was Apr 10, 2025 with a return of +3.6%, while the worst single day was Apr 4, 2025 at -5.5%.

Test 12 has an annualized alpha of 23.49%, beta of 0.26, and R² of 0.13 versus S&P 500 Index. Calculated based on daily prices since June 20, 2023.

• This portfolio captured 100.49% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -5.74%) — a profile typical of hedging or uncorrelated assets.
• Beta of 0.26 may look defensive, but with R² of 0.13 this portfolio is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
• R² of 0.13 means this portfolio moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Test 12 has an expense ratio of 0.37%, placing it in the medium range. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Test 12 ranks 97 for risk / return — in the top 97% of portfolios on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Test 12 Sharpe ratios as of Apr 2, 2026 (values are recalculated daily):

• 1-Year: 2.52
• All Time: 2.45

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.98 to 1.67, this portfolio's current Sharpe ratio is in the top 25%. This signifies superior risk-adjusted performance, meaning the portfolio is delivering strong returns for the level of risk taken compared to most others.

The chart below shows the rolling Sharpe ratio of Test 12 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Test 12 provided a 2.29% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Test 12. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Test 12 was 12.68%, occurring on Apr 9, 2025. Recovery took 19 trading sessions.

The current Test 12 drawdown is 1.54%.

The chart below shows the rolling one-month volatility.